EBS

Emergent BioSolutions Inc. $6.23 1M +36.9% 3M -25.7% YTD -50.2% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.1%
Next 1 week
-0.9%
Next 1 month
-0.6%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -2.1% median, 42% of the last 19 years finished up.
20-year seasonality chart →
Mean reversion
Overbought — RSI(2) at 80
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.15%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.17 -0.2% · Seasonal tilt -0.4%
$7M/day volume 78% volatility -22% 1-year
52-week range · 19% of the way up · -56% from the high
$4.36$14.06

Congressional trades in EBS Full tracker →

3 members · 7 buys / 6 sells · $27K–$230K disclosed · latest filing Jan 10, 2025.

SELL SC Steve Cohen · traded Dec 11, 2024 $1K–$15K
SELL JG Josh Gottheimer · traded Nov 5, 2021 $1K–$15K
BUY JG Josh Gottheimer · traded Oct 18, 2021 $1K–$15K
SELL JG Josh Gottheimer · traded Sep 15, 2021 $1K–$15K
SELL JG Josh Gottheimer · traded Feb 23, 2021 $1K–$15K
BUY GC Gilbert Cisneros · traded Nov 24, 2020 $1K–$15K
BUY GC Gilbert Cisneros · traded Jul 30, 2020 $1K–$15K
BUY GC Gilbert Cisneros · traded Jun 19, 2020 $1K–$15K

Earnings Full history →

Next report 2026-10-28 (Wednesday, after close, in 44 days) · EPS est. -0.39.

1-day std dev
17.4%
Finished up
48%
Biggest pop
+71.0%
Biggest drop
-42.0%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.